HealthFoundayo pill lowers heart attack, stroke risk: Eli Lilly
- 17-Apr-2026
Eli Lilly said on Thursday its newly approved obesity pill was not inferior to a widely used long-acting insulin at lowering the risk of major heart problems in patients with type 2 diabetes and obesity. The U.S. Food and Drug Administration approved the pill, Foundayo, for weight loss earlier this month, intensifying Lilly’s competition with […]
